Article
WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Journal of clinical pathology - 1 Jul 2014
Rauscher Julian, Beschorner Rudi, Gierke Midea, Bisdas Sotirios, Braun Christian, Ebner Florian H, Schittenhelm Jens
Abstract excerpt
AIMS: The zinc finger transcription factor WT1 is expressed in astrocytic neoplasms and therefore is a potential target of immunotherapy in brain tumours. Our aim was to further elucidate the role of WT1 as a diagnostic and prognostic marker in neuropathology, particularly as to the differentiation of astrocytoma from oligodendroglioma as well as to the dependency of WT1 expression on clinically relevant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
